Clinical Trial Update: Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection [Phase 3]

View source ↗

Summary

Phase 3 results of the combination of sofosbuvir and ribavirin in treatment-naive and treatment-experienced adults with chronic hepatitis C virus infection geno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED | Results posted: 2014-10-09